comparemela.com

Latest Breaking News On - Miguel martin - Page 9 : comparemela.com

Aurora Cannabis: Company purchases Australian medical firm

Aurora Cannabis Inc. bolstered its international presence Thursday with a deal to buy the 90 per cent of Australian medical cannabis company MedReleaf Australia it didn t already own.

Aurora Cannabis buys Australian medical pot firm as losses continue | iNFOnews

Aurora Cannabis buys Australian medical pot firm as losses continue | iNFOnews
infotel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotel.ca Daily Mail and Mail on Sunday newspapers.

Aurora Cannabis Inc (NASDAQ:ACB) Q3 2024 Earnings Call Transcript

Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2024 Earnings Call Transcript February 8, 2024 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.01. Aurora Cannabis Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and […]

Aurora Cannabis buys MedReleaf Australia at A$50M enterprise value (NASDAQ:ACB)

Aurora Cannabis buys MedReleaf Australia at A$50M enterprise value (NASDAQ:ACB)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Aurora Cannabis Acquires MedReleaf Australia

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canada based leading global medical cannabis company, is pleased to announce that a wholly-owned subsidiary of the Company has acquired the remaining approximately 90% equity interest of Indica Industries Pty Ltd ("MedReleaf Australia") that Aurora did not previously own, at an enterprise value of AUD$50 million, subject to customary adjustments (the "Transaction"). Aurora paid AUD$9.45 million in cash with the balanc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.